소포로리피드 및 람노리피드 시장 예측(-2034년) : 종류, 용도, 지역별 세계 분석

According to Stratistics MRC, the Global Sophorolipid and Rhamnolipid Market is accounted for $458.7 million in 2026 and is expected to reach $861.4 million by 2034 growing at a CAGR of 8.2% during the forecast period. Biosurfactants, a class of environmentally benign substances with a wide range of uses, include sophorolipids and rhamnolipids. Yeast, usually Candida bombicola, produces sophorolipids, which have good surface-active qualities and can be used in a variety of industrial and environmental applications, including enhanced oil recovery and bioremediation. Moreover, rhamnolipids have drawn interest because of their potential for use as emulsifiers in the food and cosmetics industries, as well as for the biodegradation of hydrophobic pollutants.

According to the American Chemical Society, biosurfactants such as sophorolipids and rhamnolipids are gaining prominence as environmentally friendly alternatives with diverse applications in industries ranging from bioremediation to enhanced oil recovery.

Market Dynamics:

Driver:

Growing need for eco-friendly remedies

The demand for sophorolipid and rhamnolipid is rising as a result of the global shift towards environmentally friendly and sustainable solutions. A growing number of industries and consumers are looking for alternatives with less of an impact on the environment. Because they come from microbial sources, sophorolipids and rhamnolipids are acknowledged for their renewable nature and suitability for use in sustainable practices. Additionally, the growing need for bio-based surfactants is in line with the larger goal of reducing dependency on products derived from petrochemicals, which is encouraging the development of these biosurfactants in a range of applications.

Restraint:

Production expenses and scaling issues

The market for sophorolipids and rhamnolipids is hampered, in part, by issues with scalability and production costs. Although these biosurfactants provide environmentally friendly substitutes, they can be more expensive to produce than conventional chemical surfactants, especially when manufactured on a large scale. However, widespread adoption is still hampered by difficulties in boosting production processes, guaranteeing consistency in quality, and achieving cost competitiveness.

Opportunity:

Expanding uses for agrochemicals and agriculture

The fields of agriculture and agrochemicals present bright prospects for sophorolipids and rhamnolipids. By improving their spreading and adherence on plant surfaces, their surfactant qualities can improve the efficacy of agrochemical formulations. Further evidence suggests that these biosurfactants may help to mitigate soil-borne diseases and encourage plant growth. Moreover, sophorolipids and rhamnolipids may be important in the development of bio-based agrochemical solutions as the demand for environmentally friendly and sustainable agricultural practices rises.

Threat:

Synthetic Alternatives Competition

The market for sophorolipids and rhamnolipids is constantly threatened by fierce competition from well-known synthetic surfactants. Conventional chemical surfactants have a well-established performance profile, a large market presence, and cheaper production costs. Furthermore, persuading industries to switch from well-known synthetic surfactants to bio-based ones is a difficult task because there may be doubts about the bio-based surfactants' efficacy, consistency, and affordability.

Covid-19 Impact:

The sophorolipid and rhamnolipid markets have been impacted by the COVID-19 pandemic in many ways. Lockdowns, economic uncertainty, and disruptions in global supply chains have made it difficult to produce and distribute these bio-based surfactants, which has an impact on their availability. The need for eco-friendly solutions has grown due to the growing emphasis on sustainability and hygiene, but economic downturns and cautious spending across industries have restrained the market's overall growth. Nonetheless, in the post-pandemic environment, prospects for recovery and future expansion are presented by the biotechnology industry's tenacity and the continuous transition to sustainable practices.

The Sophorolipids segment is expected to be the largest during the forecast period

It is projected that the sophorolipids segment will have the largest share. Sophorolipids are in high demand because of their many uses in the pharmaceutical, cosmetic, and agricultural industries. Because of their effectiveness as bio-based surfactants and the increasing public and governmental support for sustainable alternatives, sophorolipids are now a major player in the market. Moreover, the distinctive characteristics of sophorolipids, such as their low toxicity and biodegradability, add to their popularity in environmentally conscious industries.

The Healthcare and Pharmaceuticals segment is expected to have the highest CAGR during the forecast period

The healthcare and pharmaceuticals segment is growing at the highest CAGR. The growth of this market has been driven by the growing use of these bio-based surfactants in drug delivery systems, pharmaceutical formulations, and medical applications. Due to their low toxicity, biocompatibility, and antimicrobial qualities, sophorolipids and rhamnolipids are excellent choices for usage in pharmaceutical and healthcare products. Furthermore, the high growth of the sector can be attributed to their potential applications in wound care and medical device coatings, as well as their capacity to improve the solubility and bioavailability of specific drugs.

Region with largest share:

The market's largest share is predicted to belong to North America. The dominance of the region is ascribed to various factors, including a firmly established industrial sector, abundant research and development endeavors, and a pronounced focus on sustainability. The adoption of bio-based solutions in a variety of industries, such as household detergents, cosmetics, and pharmaceuticals, has been spearheaded by the United States in particular. Moreover, North America leads the world in both the sophorolipid and rhamnolipid markets, partly due to regulatory support for eco-friendly alternatives and the presence of important players in the industry.

Region with highest CAGR:

The Asia-Pacific region is projected to have the highest CAGR. The need for environmentally friendly and sustainable solutions has grown as a result of the region's changing economic environment and quickly growing industrial sector. Bio-based surfactants are being used more often in China and India for a variety of applications, including cosmetics, pharmaceuticals, and agriculture. Additionally, growing environmental consciousness and a move toward green technologies are advantageous to the Asia-Pacific region.

Key players in the market

Some of the key players in Sophorolipid and Rhamnolipid market include Givaudan SA, Dow Inc, Allied Carbon Solutions Co Ltd, Holiferm Ltd, Evonik Industries AG, Godrej Industries Ltd, Jeneil Bioproducts GmbH, Saraya Co. Ltd, Deguan Biosurfactant Supplier and Stepan Co.

Key Developments:

In May 2023, Dow and New Energy Blue announced a long-term supply agreement in North America in which New Energy Blue will create bio-based ethylene from renewable agricultural residues. Dow expects to purchase this bio-based ethylene, reducing carbon emissions from plastic production, and using it in recyclable applications across transportation, footwear, and packaging.

In April 2023, Givaudan, the global leader in Fragrance & Beauty, today announces that it has completed the acquisition of major cosmetic ingredients portfolio from Amyris, Inc. Givaudan had announced that it had reached an agreement for this transaction. Amyris is a leading biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market(TM) technology platform in beauty, health & wellness and flavours & fragrances markets.

In November 2022, Evonik has entered into an agreement to supply blueSulfate, a liquid ammonium sulfate (8-0-0-9) solution from its site in Mobile, AL, to Interoceanic Corporation (IOC). This agreement supports Evonik's strategy to focus on its core business in Animal Nutrition by marketing one of the co-products of its methionine production network via IOC.

Types Covered:

• Sophorolipids
• Rhamnolipids
• Other Types

Applications Covered:

• Oil and Gas
• Agriculture
• Healthcare and Pharmaceuticals
• Food and Beverage
• Household Detergents
• Industrial and Institutional Cleaners
• Cosmetics and Personal Care
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Sophorolipid and Rhamnolipid Market, By Type

• 5.1 Introduction
• 5.2 Sophorolipids
  • 5.2.1 High-purity Sophorolipids
  • 5.2.2 Low-purity Sophorolipids
• 5.3 Rhamnolipids
  • 5.3.1 Mono-Rhamnolipids
  • 5.3.2 Di-Rhamnolipids
• 5.4 Other Types

6 Global Sophorolipid and Rhamnolipid Market, By Application

• 6.1 Introduction
• 6.2 Oil and Gas
• 6.3 Agriculture
• 6.4 Healthcare and Pharmaceuticals
• 6.5 Food and Beverage
• 6.6 Household Detergents
• 6.7 Industrial and Institutional Cleaners
• 6.8 Cosmetics and Personal Care
• 6.9 Other Applications

7 Global Sophorolipid and Rhamnolipid Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Givaudan SA
• 9.2 Dow Inc
• 9.3 Allied Carbon Solutions Co Ltd
• 9.4 Holiferm Ltd
• 9.5 Evonik Industries AG
• 9.6 Godrej Industries Ltd
• 9.7 Jeneil Bioproducts GmbH
• 9.8 Saraya Co. Ltd
• 9.9 Deguan Biosurfactant Supplier
• 9.10 Stepan Co